Longitudinal patterns of bone-targeted agent use among patients with solid tumors and bone metastases in the United States
ConclusionsThis is the first study reporting long-term treatment patterns for the two primary BTAs used in the USA. The greater compliance and longer persistence observed among denosumab patients may improve treatment effectiveness achieved in the real-world setting.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Electronic Medical Records (EMR) | Reclast | Study | Xgeva | Zometa